HOTH Projected Dividend Yield
Hoth Therapeutics Inc ( NASDAQ : HOTH )Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs. Co. is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). In addition, Co. is evaluating a peptide that may be used to slow the transmission of SARS-CoV-2 (HT-002). Co. is also developing a diagnostic device via a mobile device. Co. has interests in assets being developed by third parties including a treatment for patients with lupus. 20 YEAR PERFORMANCE RESULTS |
HOTH Dividend History Detail HOTH Dividend News HOTH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |